GMA-306

N/A

Report date: 2025/01/03 14:50:12

Base Information

Drug NameGMA-306
Drug Alias NameGMA-306
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTransforming growth factor beta inhibitorsEndothelin receptor type A modulators
TargetsTransforming growth factor betaEndothelin receptor type A
Therapy Area/IndicationsHeart FailurePulmonary FibrosisPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGmax Biopharm Llc
China Registration ClassN/A

Develop Information

Active CompaniesGmax Biopharm Llc
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsPulmonary FibrosisPulmonary Arterial Hypertension

Other Information

ATC CodeN/A
Related LinksN/A